Identification of virulence determinants within the L genomic segment of the pichinde arenavirus

Journal of Virology

Volumn 87, Issue 12, 2013, Pages 6635-6643

  McLay, Lisa ^a   Lan, Shuiyun ^a   Ansari, Aftab ^a   Liang, Yuying ^b   Ly, Hinh ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; GUINEA PIG; LASSA FEVER; LASSA VIRUS; MALE; NONHUMAN; PICHINDE ARENAVIRUS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE GENETICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; VIRUS GENE; VIRUS GENOME; VIRUS HEMORRHAGIC FEVER; VIRUS REPLICATION; VIRUS STRAIN; VIRUS VIRULENCE;

ANIMALS; ARENAVIRIDAE INFECTIONS; CERCOPITHECUS AETHIOPS; DNA-DIRECTED RNA POLYMERASES; GENOMICS; GUINEA PIGS; HUMANS; LIVER; MALE; PICHINDE VIRUS; POINT MUTATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; VERO CELLS; VIRAL PROTEINS; VIRULENCE; VIRUS REPLICATION;

ANIMALIA; CAVIA; LASSA VIRUS; PICHINDE VIRUS;

EID: 84878561530     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00044-13     Document Type: Article

References (62)

1. Buchmeier M, Bowen M, Peters C. 2001. Arenaviridae: the viruses and their replication, p 1635-1668. In Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (ed), Fields virology, 4th ed, vol 2. Lippincott Williams & Wilkins, Philadelphia, PA.
2. Wilson S, Clegg J. 1991. Sequence analysis of the S RNA of the African arenavirus Mopeia: an unusual secondary structure feature in the intergenic region. Virology 180:543-552.
3. Hass M, Westerkofsky M, Müller S, Becker-Ziaja B, Busch C, Günther S. 2006. Mutational analysis of the Lassa virus promoter. J. Virol. 80: 12414-12419.
4. Lee KJ, de la Torre JC. 2002. Reverse genetics of arenaviruses. Curr. Top. Microbiol. Immunol. 262:175-193.
5. Perez M, de la Torre JC. 2003. Characterization of the genomic promoter of the prototypic arenavirus lymphocytic choriomeningitis virus. J. Virol. 77:1184-1194.
6. Hass M, Gölnitz U, Müller S, Becker-Ziaja B, Günther S. 2004. Replicon system for Lassa virus. J. Virol. 78:13793-13803.
7. Lee KJ, Novella IS, Teng MN, Oldstone MBA, de la Torre JC. 2000. NP and L proteins of lymphocytic choriomeningitis virus (LCMV) are sufficient for efficient transcription and replication of LCMV genomic RNA analogs. J. Virol. 74:3470-3477.
8. López N, Jácamo R,Franze-Fernández MT. 2001. Transcription and RNA replication of Tacaribe virus genome and antigenome analogs require N and L proteins: Z protein is an inhibitor of these processes. J. Virol. 75:12241-12251.
9. Martínez-Sobrido L, Emonet S, Giannakas P, Cubitt B, García-Sastre A, de la Torre JC. 2009. Identification of amino acid residues critical for the anti-interferon activity of the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus. J. Virol. 83:11330-11340.
10. Martínez-Sobrido L, Giannakas P, Cubitt B, García-Sastre A, de la Torre JC. 2007. Differential inhibition of type I interferon induction by arenavirus nucleoproteins. J. Virol. 81:12696-12703.
11. Martínez-Sobrido L, Zúñiga EI, Rosario D, García-Sastre A, de la Torre JC. 2006. Inhibition of the type I interferon response by the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus. J. Virol. 80:9192-9199.
12. Qi X, Lan S, Wang W, Schelde LM, Dong H, Wallat GD, Ly H, Liang Y, Dong C. 2010. Cap binding and immune evasion revealed by Lassa nucleoprotein structure. Nature 468:779-783.
13. Günther S, Lenz O. 2004. Lassa virus. Crit. Rev. Clin. Lab. Sci. 41:339-390.
14. McCormick J, Webb P, Krebs J, Johnson K, Smith E. 1987. A prospective study of the epidemiology and ecology of Lassa fever. J. Infect. Dis. 155:437-444.
15. Walker D, McCormick J, Johnson K, Webb P, Komba-Kono G, Elliott L, Gardner J. 1982. Pathologic and virologic study of fatal Lassa fever in man. Am. J. Pathol. 107:349-356.
16. Johnson KM, McCormick JB, Webb PA, Smith ES, Elliott LH, King IJ. 1987. Clinical virology of Lassa fever in hospitalized patients. J. Infect. Dis. 155:456-464.
17. Oldstone MBA, Campbell KP. 2011. Decoding arenavirus pathogenesis: essential roles for alpha-dystroglycan-virus interactions and the immune response. Virology 411:170-179.
18. McCormick JB, King IJ, Webb PA, Scribner CL, Craven RB, Johnson KM, Elliott LH, Belmont-Williams R. 1986. Lassa fever. N. Engl. J. Med. 314:20-26.
19. McCormick JB, King IJ, Webb PA, Johnson KM, O'Sullivan R, Smith ES, Trippel S, Tong TC. 1987. A case-control study of the clinical diagnosis and course of Lassa fever. J. Infect. Dis. 155:445-455.
20. Aronson J, Herzog N, Jerrells T. 1994. Pathological and virological features of arenavirus disease in guinea pigs. Comparison of two Pichinde virus strains. Am. J. Pathol. 145:228-235.
21. Jahrling PB, Hesse RA, Rhoderick JB, Elwell MA, Moe JB. 1981. Pathogenesis of a Pichinde virus strain adapted to produce lethal infections in guinea pigs. Infect. Immun. 32:872-880.
22. Aronson J, Herzog N, Jerrells T. 1995. Tumor necrosis factor and the pathogenesis of Pichinde virus infection in guinea pigs. Am. J. Trop. Med. Hyg. 52:262-269.
23. Bowick GC, Fennewald SM, Elsom BL, Aronson JF, Luxon BA, Gorenstein DG, Herzog NK. 2006. Differential signaling networks induced by mild and lethal hemorrhagic fever virus infections. J. Virol. 80:10248-10252.
24. Connolly BM, Jenson AB, Peters CJ, Geyer SJ, Barth JF, McPherson RA. 1993. Pathogenesis of Pichinde virus infection in strain 13 guinea pigs: an immunocytochemical, virologic, and clinical chemistry study. Am. J. Trop. Med. Hyg. 49:10-24.
25. Fennewald SM, Aronson JF, Zhang L, Herzog NK. 2002. Alterations in NF-B and RBP-J. by arenavirus infection of macrophages in vitro and in vivo. J. Virol. 76:1154-1162.
26. Katz MA, Starr JF. 1990. Pichinde virus infection in strain 13 guinea pigs reduces intestinal protein reflection coefficient with compensation. J. Infect. Dis. 162:1304-1308.
27. Lucia HL, Coppenhaver DH, Harrison RL, Baron S. 1990. The effect of an arenavirus infection on liver morphology and function. Am. J. Trop. Med. Hyg. 43:93-98.
28. Peters C, Liu C, Anderson G, Morrill J, Jahrling P. 1989. Pathogenesis of viral hemorrhagic fevers: Rift Valley fever and Lassa fever contrasted. Rev. Infect. Dis. 11(Suppl 4):S743-S749.
29. Qian C, Jahrling PB, Peters C, Liu C. 1994. Cardiovascular and pulmonary responses to Pichinde virus infection in strain 13 guinea pigs. Lab. Anim. Sci. 44:600-607.
30. Lan S, McLay Schelde L, Wang J, Kumar N, Ly H, Liang Y. 2009. Development of infectious clones for virulent and avirulent Pichinde viruses: a model virus to study arenavirus-induced hemorrhagic fevers. J. Virol. 83:6357-6362.
31. Zhang L, Marriott K, Aronson JF. 1999. Sequence analysis of the small RNA segment of guinea pig-passaged Pichinde virus variants. Am. J. Trop. Med. Hyg. 61:220-225.
32. Lan S, McLay L, Aronson J, Ly H, Liang Y. 2008. Genome comparison of virulent and avirulent strains of the Pichinde arenavirus. Arch. Virol. 153:1241-1250.
33. Zhang L, Marriott KA, Harnish DG, Aronson JF. 2001. Reassortant analysis of guinea pig virulence of Pichinde virus variants. Virology 290: 30-38.
34. Liang Y, Lan S, Ly H. 2009. Molecular determinants of Pichinde virus infection of guinea pigs-a small animal model system for arenaviral hemorrhagic fevers. Ann. N. Y. Acad. Sci. 1171:E65-E74. doi:10.1111/j.1749-6632.2009.05051.x.
35. Bergthaler A, Flatz L, Hegazy AN, Johnson S, Horvath E, Löhning M, Pinschewer DD. 2010. Viral replicative capacity is the primary determinant of lymphocytic choriomeningitis virus persistence and immunosuppression. Proc. Natl. Acad. Sci. U. S. A. 107:21641-21646.
36. Tarendeau F, Boudet J, Guilligay D, Mas PJ, Bougault CM, Boulo S, Baudin F, Ruigrok RWH, Daigle N, Ellenberg J, Cusack S, Simorre J-P, Hart DJ. 2007. Structure and nuclear import function of the C-terminal domain of influenza virus polymerase PB2 subunit. Nat. Struct. Mol. Biol. 14:229-233.
37. He X, Zhou J, Bartlam M, Zhang R, Ma J, Lou Z, Li X, Li J, Joachimiak A, Zeng Z, Ge R, Rao Z, Liu Y. 2008. Crystal structure of the polymerase PAC-PB1N complex from an avian influenza H5N1 virus. Nature 454: 1123-1126.
38. Brunotte L, Lelke M, Hass M, Kleinsteuber K, Becker-Ziaja B, Günther S. 2011. Domain structure of Lassa virus L protein. J. Virol. 85:324-333.
39. Morin B, Coutard B, Lelke M, Ferron F, Kerber R, Jamal S, Frangeul A, Baronti C, Charrel R, de Lamballerie X, Vonrhein C, Lescar J, Bricogne G, Günther S, Canard B. 2010. The N-terminal domain of the arenavirus L protein is an RNA endonuclease essential in mRNA transcription. PLoS Pathog. 6:e1001038. doi:10.1371/journal.ppat.1001038.
40. Wilda M, Lopez N, Casabona JC, Franze-Fernandez MT. 2008. Mapping of the Tacaribe arenavirus Z-protein binding sites on the L protein identified both amino acids within the putative polymerase domain and a region at the N terminus of L that are critically involved in binding. J. Virol. 82:11454-11460.
41. Sánchez AB, de la Torre JC. 2005. Genetic and biochemical evidence for an oligomeric structure of the functional L polymerase of the prototypic arenavirus lymphocytic choriomeningitis virus. J. Virol. 79:7262-7268.
42. Smallwood S, Çevik B, Moyer SA. 2002. Intragenic complementation and oligomerization of the L subunit of the Sendai virus RNA polymerase. Virology 304:235-245.
43. Smallwood S, Moyer SA. 2004. The L polymerase protein of parainfluenza virus 3 forms an oligomer and can interact with the heterologous Sendai virus L, P and C proteins. Virology 318:439-450.
44. Zamoto-Niikura A, Terasaki K, Ikegami T, Peters CJ, Makino S. 2009. Rift Valley fever virus L protein forms a biologically active oligomer. J. Virol. 83:12779-12789.
45. Ping J, Dankar SK, Forbes NE, Keleta L, Zhou Y, Tyler S, Brown EG. 2010. PB2 and hemagglutinin mutations are major determinants of host range and virulence in mouse-adapted influenza A virus. J. Virol. 84: 10606-10618.
46. Tada T, Suzuki K, Sakurai Y, Kubo M, Okada H, Itoh T, Tsukamoto K. 2011. NP body domain and PB2 contribute to increased virulence of H5N1 highly pathogenic avian influenza viruses in chickens. J. Virol. 85: 1834-1846.
47. Xu L, Bao L, Zhou J, Wang D, Deng W, Lv Q, Ma Y, Li F, Sun H, Zhan L, Zhu H, Ma C, Shu Y, Qin C. 2011. Genomic polymorphism of the pandemic A (H1N1) influenza viruses correlates with viral replication, virulence, and pathogenicity in vitro and in vivo. PLoS One 6:e20698. doi: 10.1371/journal.pone.0020698.
48. Kunz S, Sevilla N, McGavern DB, Campbell KP, Oldstone MBA. 2001. Molecular analysis of the interaction of LCMV with its cellular receptor -dystroglycan. J. Cell Biol. 155:301-310.
49. Smelt SC, Borrow P, Kunz S, Cao W, Tishon A, Lewicki H, Campbell KP, Oldstone MBA. 2001. Differences in affinity of binding of lymphocytic choriomeningitis virus strains to the cellular receptor -dystroglycan correlate with viral tropism and disease kinetics. J. Virol. 75:448-457.
50. Flanagan ML, Oldenburg J, Reignier T, Holt N, Hamilton GA, Martin VK, Cannon PM. 2008. New World clade B arenaviruses can use transferrin receptor 1 (TfR1)-dependent and -independent entry pathways, and glycoproteins from human pathogenic strains are associated with the use of TfR1. J. Virol. 82:938-948.
51. Radoshitzky SR, Abraham J, Spiropoulou CF, Kuhn JH, Nguyen D, Li W, Nagel J, Schmidt PJ, Nunberg JH, Andrews NC, Farzan M, Choe H. 2007. Transferrin receptor 1 is a cellular receptor for New World haemorrhagic fever arenaviruses. Nature 446:92-96.
52. Abraham J, Kwong JA, Albariño CG, Lu JG, Radoshitzky SR, Salazar- Bravo J, Farzan M, Spiropoulou CF, Choe H. 2009. Host-species transferrin receptor 1 orthologs are cellular receptors for nonpathogenic New World clade B arenaviruses. PLoS Pathog. 5:e1000358. doi:10.1371/journal.ppat.1000358.
53. Cao W, Henry M, Borrow P, Yamada H, Elder J, Ravkov E, Nichol S, Compans R, Campbell K, Oldstone M. 1998. Identification of alphadystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus. Science 282:2079-2081.
54. Baize S, Kaplon J, Faure C, Pannetier D, Georges-Courbot M-C, Deubel V. 2004. Lassa virus infection of human dendritic cells and macrophages is productive but fails to activate cells. J. Immunol. 172:2861-2869.
55. Baize S, Marianneau P, Loth P, Reynard S, Journeaux A, Chevallier M, Tordo N, Deubel V, Contamin H. 2009. Early and strong immune responses are associated with control of viral replication and recovery in Lassa virus-infected cynomolgus monkeys. J. Virol. 83:5890-5903.
56. Edington G, White H. 1972. The pathology of Lassa fever. Trans. R. Soc. Trop. Med. Hyg. 66:381-389.
57. Fisher-Hoch S, McCormick J, Sasso D, Craven R. 1988. Hematologic dysfunction in Lassa fever. J. Med. Virol. 26:127-135.
58. Mahanty S, Hutchinson K, Agarwal S, McRae M, Rollin PE, Pulendran B. 2003. Cutting edge: impairment of dendritic cells and adaptive immunity by Ebola and Lassa viruses. J. Immunol. 170:2797-2801.
59. McCormick J, Fisher-Hoch S. 2002. Lassa fever. Curr. Top. Microbiol. Immunol. 262:75-109.
60. Müller S, Geffers R, Günther S. 2007. Analysis of gene expression in Lassa virus-infected HuH-7 cells. J. Gen. Virol. 88:1568-1575.
61. Brunotte L, Kerber R, Shang W, Hauer F, Hass M, Gabriel M, Lelke M, Busch C, Stark H, Svergun DI, Betzel C, Perbandt M, Günther S. 2011. Structure of the Lassa virus nucleoprotein revealed by X-ray crystallography, small-angle X-ray scattering, and electron microscopy. J. Biol. Chem. 286:38748-38756.
62. Hastie KM, Kimberlin CR, Zandonatti MA, MacRae IJ, Saphire EO. 2011. Structure of the Lassa virus nucleoprotein reveals a dsRNA-specific 3' to 5' exonuclease activity essential for immune suppression. Proc. Natl. Acad. Sci. U. S. A. 108:2396-2401.